The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group
The term monoclonal gammopathy of renal significance (MGRS) was introduced by the
International Kidney and Monoclonal Gammopathy Research Group (IKMG) in 2012. The …
International Kidney and Monoclonal Gammopathy Research Group (IKMG) in 2012. The …
How I manage monoclonal gammopathy of undetermined significance
RS Go, SV Rajkumar - Blood, The Journal of the American …, 2018 - ashpublications.org
Monoclonal gammopathy of undetermined significance (MGUS) is, in many ways, a unique
hematologic entity. Unlike most hematologic conditions in which the diagnosis is intentional …
hematologic entity. Unlike most hematologic conditions in which the diagnosis is intentional …
[HTML][HTML] British Thoracic Society Guideline for bronchiectasis in adults
CT scanning can also aid in identifying an aetiology of bronchiectasis eg Allergic
bronchopulmonary aspergillosis (ABPA), Non-tuberculous mycobacteria (NTM), primary …
bronchopulmonary aspergillosis (ABPA), Non-tuberculous mycobacteria (NTM), primary …
Cutaneous manifestations of monoclonal gammopathy
JS Claveau, DA Wetter, S Kumar - Blood cancer journal, 2022 - nature.com
Monoclonal gammopathy associated with dermatological manifestations are a well-
recognized complication. These skin disorders can be associated with infiltration and …
recognized complication. These skin disorders can be associated with infiltration and …
Mass spectrometry for identification, monitoring, and minimal residual disease detection of M-proteins
M Zajec, P Langerhorst, MM VanDuijn… - Clinical …, 2020 - academic.oup.com
Abstract Background Monoclonal gammopathies (MGs) are plasma cell disorders defined by
the clonal expansion of plasma cells, resulting in the characteristic excretion of a …
the clonal expansion of plasma cells, resulting in the characteristic excretion of a …
Direct mass spectrometry-based detection and antibody sequencing of monoclonal gammopathy of undetermined significance from patient serum: A case study
W Peng, MA den Boer, S Tamara… - Journal of Proteome …, 2023 - ACS Publications
Monoclonal gammopathy of undetermined significance (MGUS) is a plasma cell disorder
characterized by the presence of a predominant monoclonal antibody (ie, M-protein) in …
characterized by the presence of a predominant monoclonal antibody (ie, M-protein) in …
Dysproteinemias and glomerular disease
Dysproteinemia is characterized by the overproduction of an Ig by clonal expansion of cells
from the B cell lineage. The resultant monoclonal protein can be composed of the entire Ig or …
from the B cell lineage. The resultant monoclonal protein can be composed of the entire Ig or …
An international multi-center serum protein electrophoresis accuracy and M-protein isotyping study. Part II: limit of detection and follow-up of patients with small M …
JFM Jacobs, KA Turner, MS Graziani… - Clinical Chemistry and …, 2020 - degruyter.com
Background Electrophoretic methods to detect, characterize and quantify M-proteins play an
important role in the management of patients with monoclonal gammopathies (MGs) …
important role in the management of patients with monoclonal gammopathies (MGs) …
Enumeration and characterization of circulating multiple myeloma cells in patients with plasma cell disorders
B Foulk, M Schaffer, S Gross, C Rao… - British Journal of …, 2018 - Wiley Online Library
We have developed an automated assay to enumerate and characterize circulating multiple
myeloma cells (CMMC) from peripheral blood of patients with plasma cell disorders. CMMC …
myeloma cells (CMMC) from peripheral blood of patients with plasma cell disorders. CMMC …
Free Light Chains κ and λ as New Biomarkers of Selected Diseases
M Gudowska-Sawczuk, B Mroczko - International Journal of Molecular …, 2023 - mdpi.com
Diagnostic and prognostic markers are necessary to help in patient diagnosis and the
prediction of future clinical events or disease progression. As promising biomarkers of …
prediction of future clinical events or disease progression. As promising biomarkers of …